1. Home
  2. BCDA vs LUCY Comparison

BCDA vs LUCY Comparison

Compare BCDA & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.44

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo Innovative Eyewear Inc.

LUCY

Innovative Eyewear Inc.

HOLD

Current Price

$1.43

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
LUCY
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
7.7M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BCDA
LUCY
Price
$1.44
$1.43
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
64.8K
279.8K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,392,547.00
Revenue This Year
N/A
$80.76
Revenue Next Year
N/A
$210.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.22
52 Week Low
$1.00
$1.29
52 Week High
$3.20
$7.08

Technical Indicators

Market Signals
Indicator
BCDA
LUCY
Relative Strength Index (RSI) 54.71 42.78
Support Level $1.36 $1.38
Resistance Level $1.50 $1.68
Average True Range (ATR) 0.07 0.12
MACD 0.01 0.02
Stochastic Oscillator 72.35 34.88

Price Performance

Historical Comparison
BCDA
LUCY

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.

Share on Social Networks: